De Bruin ML - Search Results

1

Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports.

Klein K, Scholl JH, Vermeer NS, Broekmans AW, Van Puijenbroek EP, De Bruin ML, Stolk P. Klein K, et al. Among authors: de bruin ml. Drug Saf. 2016 Feb;39(2):185-92. doi: 10.1007/s40264-015-0383-8. Drug Saf. 2016. PMID: 26719190 Free PMC article.

2

Non-sedating antihistamine drugs and cardiac arrhythmias -- biased risk estimates from spontaneous reporting systems?

De Bruin ML, van Puijenbroek EP, Egberts AC, Hoes AW, Leufkens HG. De Bruin ML, et al. Br J Clin Pharmacol. 2002 Apr;53(4):370-4. doi: 10.1046/j.1365-2125.2002.01569.x. Br J Clin Pharmacol. 2002. PMID: 11966667 Free PMC article.

3

Pharmacogenetics of drug-induced arrhythmias: a feasibility study using spontaneous adverse drug reactions reporting data.

De Bruin ML, van Puijenbroek EP, Bracke M, Hoes AW, Leufkens HG. De Bruin ML, et al. Pharmacoepidemiol Drug Saf. 2006 Feb;15(2):99-105. doi: 10.1002/pds.1194. Pharmacoepidemiol Drug Saf. 2006. PMID: 16329159

4

[Research into the risk of malignancy from biologicals: utility of meta-analysis hampered].

Vermeer NS, De Bruin ML. Vermeer NS, et al. Among authors: de bruin ml. Ned Tijdschr Geneeskd. 2013;157(6):A5884. Ned Tijdschr Geneeskd. 2013. PMID: 23388143 Dutch.

5

Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases.

Vermeer NS, Straus SM, Mantel-Teeuwisse AK, Domergue F, Egberts TC, Leufkens HG, De Bruin ML. Vermeer NS, et al. Among authors: de bruin ml. Drug Saf. 2013 Aug;36(8):617-25. doi: 10.1007/s40264-013-0073-3. Drug Saf. 2013. PMID: 23771794

6

The post hoc use of randomised controlled trials to explore drug associated cancer outcomes: methodological challenges.

Stefansdottir G, Zoungas S, Chalmers J, Knol MJ, Leufkens HG, Woodward M, Patel A, Grobbee DE, De Bruin ML. Stefansdottir G, et al. Among authors: de bruin ml. Curr Drug Saf. 2013 Nov;8(5):371-8. doi: 10.2174/15748863113086660070. Curr Drug Saf. 2013. PMID: 24215314 Review.

7

Use of metformin and survival of diabetic women with breast cancer.

Peeters PJ, Bazelier MT, Vestergaard P, Leufkens HG, Schmidt MK, de Vries F, De Bruin ML. Peeters PJ, et al. Among authors: de vries f, de bruin ml. Curr Drug Saf. 2013 Nov;8(5):357-63. doi: 10.2174/15680266113136660069. Curr Drug Saf. 2013. PMID: 24215316 Free PMC article.

8

Risk management plans as a tool for proactive pharmacovigilance: a cohort study of newly approved drugs in Europe.

Vermeer NS, Duijnhoven RG, Straus SM, Mantel-Teeuwisse AK, Arlett PR, Egberts AC, Leufkens HG, De Bruin ML. Vermeer NS, et al. Among authors: de bruin ml. Clin Pharmacol Ther. 2014 Dec;96(6):723-31. doi: 10.1038/clpt.2014.184. Epub 2014 Sep 15. Clin Pharmacol Ther. 2014. PMID: 25222619

9

Traceability of biologicals: present challenges in pharmacovigilance.

Vermeer NS, Spierings I, Mantel-Teeuwisse AK, Straus SM, Giezen TJ, Leufkens HG, Egberts TC, De Bruin ML. Vermeer NS, et al. Among authors: de bruin ml. Expert Opin Drug Saf. 2015 Jan;14(1):63-72. doi: 10.1517/14740338.2015.972362. Epub 2014 Nov 5. Expert Opin Drug Saf. 2015. PMID: 25369769 Review.

10

Epidemiology of adverse drug reactions in Europe: a review of recent observational studies.

Bouvy JC, De Bruin ML, Koopmanschap MA. Bouvy JC, et al. Among authors: de bruin ml. Drug Saf. 2015 May;38(5):437-53. doi: 10.1007/s40264-015-0281-0. Drug Saf. 2015. PMID: 25822400 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters